Localization of the type 3 iodothyronine deiodinase (DIO3) gene to human chromosome 14q32 and mouse chromosome 12F1.

1. Bray-Ward, P., Menninger, J., Lieman, J., Desai, T., Mokady, N., Banks, A., and Ward, C. (1996). Integration of cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones. Genomics 32: 1–14. 2. Oosterwijk, E., Ruiter, D. J., Hoedemaeker, P. J., Pauwels, E. K. J., Jonas, U., Zwartendijk, J., and Warnaar, S. O. (1986). Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int. J. Cancer 38: 489–494. 3. Pastorek, J., Pastoreková, S., Callebaut, I., Mornon, J. P., Zelnı́k, V., Opavsky, R., Zat’ovicová, M., Liao, S., Pertetelle, D., Stanbridge, E. J., Závada, J., Burny, A., and Kettmann, R. (1994). Cloning and characterization of MN, a human tumorassociated protein with a domain homologous to carbonic anhydrase and a putative helix–loop–helix DNA binding segment. Oncogene 9: 2877–2888. 4. Pastoreková, S., Závadová, Z., Kost’al, M., Babusı́ková, O., and Závada, J. (1992). A novel quasi-viral agent, TaTu, is a twocomponent system. Virology 187: 620–626. 5. Závada, J., Závadová, Z., Malir, A., and Kocent, A. (1972). VSV pseudotype produced in cell line derived from human mammary carcinoma. Nat. New Biol. 240: 124–125.